Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroinflammation in Alzheimer’s Disease: Current Progress in Molecular Signaling and Therapeutics
Sujata Thakur, Rishika Dhapola, Phulen Sarma, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 1-17
Closed Access | Times Cited: 248

Showing 1-25 of 248 citing articles:

Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues
Sneha Kumari, Rishika Dhapola, Dibbanti HariKrishnaReddy
APOPTOSIS (2023) Vol. 28, Iss. 7-8, pp. 943-957
Closed Access | Times Cited: 128
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Oxidative stress in Alzheimer’s disease: current knowledge of signaling pathways and therapeutics
Rishika Dhapola, Samir Kumar Beura, Prajjwal Sharma, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 62
JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 52
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Jessica R. Cohen, Annette Mathew, Kirk D. Dourvetakis, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 511-511
Open Access | Times Cited: 28
Unveiling the role of astrocytes in postoperative cognitive dysfunction
Liang He, X. Duan, Shikuo Li, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102223-102223
Closed Access | Times Cited: 17
Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects
Bushra Bashir, Monica Gulati, Sukriti Vishwas, et al.
Ageing Research Reviews (2025), pp. 102689-102689
Closed Access | Times Cited: 2
Brain metabolism in Alzheimer’s disease: biological mechanisms of exercise
Longfei Xu, Ran Liu, Yingkai Qin, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Endoplasmic reticulum stress in Alzheimer's disease: Molecular mechanisms and therapeutic prospects
Pushank Nagar, Prajjwal Sharma, Rishika Dhapola, et al.
Life Sciences (2023) Vol. 330, pp. 121983-121983
Closed Access | Times Cited: 31
Multi-omics data reveals aberrant gut microbiota-host glycerophospholipid metabolism in association with neuroinflammation in APP/PS1 mice
Xiao-hang Qian, Wangxi Hai, Siyue Chen, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 31
PPAR agonists for the treatment of neuroinflammatory diseases
Celene Titus, Md. Tozammel Hoque, Reina Bendayan
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 9-23
Closed Access | Times Cited: 28
Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectives
Zhijia Li, Bo Yin, Shuangqian Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115817-115817
Closed Access | Times Cited: 27
Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
Daniela Melchiorri, Sara Merlo, Benjamin Micallef, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
The role of high mobility group box 1 in neuroinflammatory related diseases
Jialu Mo, Jiao Hu, Xianglin Cheng
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114541-114541
Open Access | Times Cited: 22
The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle
Yu Cai, Yin Zhang, Shuo Leng, et al.
Neurobiology of Disease (2024) Vol. 192, pp. 106426-106426
Open Access | Times Cited: 14
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 14
Neuroinflammation in Alzheimer disease
Wiesje M. van der Flier, Wiesje M. van der Flier, Frank Jessen, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 14
Vitamin D as a Modulator of Neuroinflammation: Implications for Brain Health
Sebastián García Menéndez, Walter Manucha
Current Pharmaceutical Design (2024) Vol. 30, Iss. 5, pp. 323-332
Closed Access | Times Cited: 13
The role of CD56bright NK cells in neurodegenerative disorders
Carla Rodriguez-Mogeda, Chaja M. J. van Ansenwoude, Lennart van der Molen, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Implications of organophosphate pesticides on brain cells and their contribution toward progression of Alzheimer's disease
Bharti Yadav, Sharanjot Kaur, Anuradha Yadav, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 3
Closed Access | Times Cited: 12
The involvement of neuroinflammation in an animal model of dementia and depression
Gabriel Casagrande Zabot, Eduarda Behenck Medeiros, Bárbara Machado Naspolini Macarini, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 110999-110999
Closed Access | Times Cited: 11
A novel Zebrafish model of Alzheimer's disease by Aluminium chloride; involving nitro-oxidative stress, neuroinflammation and cholinergic pathway
Abhishek P. R. Nadiga, Suman, K.L. Krishna
European Journal of Pharmacology (2024) Vol. 965, pp. 176332-176332
Closed Access | Times Cited: 9
Novel Development and Prospects in Pathogenesis, Diagnosis, and Therapy of Alzheimer’s Disease
Zenghui Teng
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 345-354
Open Access | Times Cited: 8
From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders
Elisa Duranti, Chiara Villa
Biology (2024) Vol. 13, Iss. 9, pp. 719-719
Open Access | Times Cited: 8
Multi-target-directed therapeutic strategies for Alzheimer’s disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition
Jeasang Yoo, Jimin Lee, Byeongha Ahn, et al.
Chemical Science (2025)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top